HK1209317A1 - Attenuated mannheimia haemolytica vaccines and methods of making and use - Google Patents

Attenuated mannheimia haemolytica vaccines and methods of making and use

Info

Publication number
HK1209317A1
HK1209317A1 HK15109964.6A HK15109964A HK1209317A1 HK 1209317 A1 HK1209317 A1 HK 1209317A1 HK 15109964 A HK15109964 A HK 15109964A HK 1209317 A1 HK1209317 A1 HK 1209317A1
Authority
HK
Hong Kong
Prior art keywords
making
methods
mannheimia haemolytica
attenuated mannheimia
haemolytica vaccines
Prior art date
Application number
HK15109964.6A
Other languages
English (en)
Chinese (zh)
Inventor
Russell F Bey
Paulraj Kirubakaran Lawrence
Randy R Simonson
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of HK1209317A1 publication Critical patent/HK1209317A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK15109964.6A 2012-11-08 2015-10-13 Attenuated mannheimia haemolytica vaccines and methods of making and use HK1209317A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261723979P 2012-11-08 2012-11-08
PCT/US2013/069144 WO2014074817A2 (en) 2012-11-08 2013-11-08 Attenuated mannheimia haemolytica vaccines and methods of making and use

Publications (1)

Publication Number Publication Date
HK1209317A1 true HK1209317A1 (en) 2016-04-01

Family

ID=50685318

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15109964.6A HK1209317A1 (en) 2012-11-08 2015-10-13 Attenuated mannheimia haemolytica vaccines and methods of making and use
HK19101075.5A HK1258694A1 (zh) 2012-11-08 2015-10-13 減毒溶血曼海姆氏菌疫苗及其製造和用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK19101075.5A HK1258694A1 (zh) 2012-11-08 2015-10-13 減毒溶血曼海姆氏菌疫苗及其製造和用途

Country Status (9)

Country Link
US (8) US9370561B2 (pt)
EP (2) EP3384927B1 (pt)
AR (1) AR093424A1 (pt)
AU (2) AU2013342269B2 (pt)
BR (1) BR112015010364B1 (pt)
CA (1) CA2890466C (pt)
ES (1) ES2684556T3 (pt)
HK (2) HK1209317A1 (pt)
WO (1) WO2014074817A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2890466C (en) 2012-11-08 2022-07-19 Merial, Inc. Attenuated mannheimia haemolytica vaccines and methods of making and use
NL2018155B1 (en) * 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
US11690901B2 (en) * 2020-03-03 2023-07-04 The United States Of America, As Represented By The Secretary Of Agriculture Southern cattle tick vaccine product
CN115960184B (zh) * 2022-09-28 2023-12-12 华中农业大学 一种溶血性曼氏杆菌a6血清型白细胞毒素抗原蛋白、其抗体及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US5055400A (en) 1986-11-26 1991-10-08 University Of Guelph Leukotoxin gene of pasteurella haemolytica
CA2014033C (en) 1989-04-07 1993-02-09 Stephen D. Acres Compositions and treatments for pneumonia in animals
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
AUPN631395A0 (en) 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(II)
US5840556A (en) 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
ATE292980T1 (de) 1996-10-11 2005-04-15 Univ California Immunostimulierende oligonucleotidekonjugate
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
AU6969798A (en) 1997-04-15 1998-11-11 Baylor College Of Medicine (pasteurella haemolytica) vaccine
US5824556A (en) 1997-06-11 1998-10-20 Tarr; George E. Peptide mass ladders generated using carbon disulfide
US6936262B2 (en) 1997-09-25 2005-08-30 Biotechnology Research And Development Corporation LktA deletion mutant of P. haemolytica
NZ514103A (en) 1997-09-25 2001-09-28 Biotechnology Res & Dev LktA deletion mutant of P. haemolytica
JP4144272B2 (ja) * 2002-07-10 2008-09-03 トヨタ自動車株式会社 内燃機関の燃料噴射量制御装置
SI1638598T1 (sl) 2003-07-02 2007-04-30 Biotechnology Res & Dev Acapsularna bakterija p. multocida mutanta z delecijo gena hyae
US9102925B2 (en) 2009-02-02 2015-08-11 Washington State University Compositions and methods for treating or preventing conditions and diseases associated with Mannheimia haemolytica
CA2890466C (en) * 2012-11-08 2022-07-19 Merial, Inc. Attenuated mannheimia haemolytica vaccines and methods of making and use
US20170022510A1 (en) 2012-11-08 2017-01-26 Biotechnology Research And Development Corporation Attenuated Mannheimia haemolytica

Also Published As

Publication number Publication date
AR093424A1 (es) 2015-06-03
US20160158336A1 (en) 2016-06-09
EP2916863B1 (en) 2018-05-30
US20160199477A1 (en) 2016-07-14
AU2013342269B2 (en) 2017-02-02
AU2013342269A1 (en) 2015-06-04
US20170304424A1 (en) 2017-10-26
EP3384927A1 (en) 2018-10-10
US20140170190A1 (en) 2014-06-19
US9675682B2 (en) 2017-06-13
CA2890466A1 (en) 2014-05-15
US20170246286A1 (en) 2017-08-31
AU2017202354A1 (en) 2017-05-11
US20190000954A1 (en) 2019-01-03
US9370561B2 (en) 2016-06-21
EP2916863A2 (en) 2015-09-16
CA2890466C (en) 2022-07-19
AU2017202354B2 (en) 2019-02-21
ES2684556T3 (es) 2018-10-03
US20160243212A1 (en) 2016-08-25
US10039819B2 (en) 2018-08-07
BR112015010364A2 (pt) 2017-08-22
WO2014074817A3 (en) 2015-07-02
WO2014074817A2 (en) 2014-05-15
US10058601B2 (en) 2018-08-28
HK1258694A1 (zh) 2019-11-15
US9744226B2 (en) 2017-08-29
US20170128560A1 (en) 2017-05-11
EP3384927B1 (en) 2022-07-06
BR112015010364B1 (pt) 2022-05-03

Similar Documents

Publication Publication Date Title
IL276761A (en) Methods of inducing coma
HK1216322A1 (zh) 組糖基轉移酶及其應用
IL239353A0 (en) Continuous production unit and methods for using it
GB201510816D0 (en) Medical tubes and methods of manufacture
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
EP2895083A4 (en) LIGATOR AND METHOD FOR ITS USE
ZA201502503B (en) Hppd variants and methods of use
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
EP2912178A4 (en) SUPER AMPLIFIER AND METHOD FOR USE THEREOF
EP2932496A4 (en) GLASS AND METHOD FOR PRODUCING GLASS ARTICLES
IL241878B (en) Macrolides and methods for their preparation and use
HK1203834A1 (en) Attenuated streptococcus suis vaccines and methods of making and use thereof
EP2844903A4 (en) TUBES AND METHOD FOR THE PRODUCTION AND USE THEREOF
EP2806811A4 (en) VERTEBRAL CONSTRUCTION
HK1221641A1 (zh) 疫苗組合物及使用方法
EP2852397A4 (en) HUWENTOXIN IV VARIANTS AND METHODS OF USE
EP2897639A4 (en) IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE
HK1209317A1 (en) Attenuated mannheimia haemolytica vaccines and methods of making and use
HK1209325A1 (en) Attenuated swine influenza vaccines and methods of making and use thereof
EP2678361A4 (en) COMPOSITIONS WITH IMPROVED IMMUNOGENICITY AND / OR REDUCED REACTIVITY AND METHOD OF USE THEREOF
EP2670245A4 (en) ALPHA-CÉTOHÉTÉROCYCLES AND METHODS OF MAKING AND USING THEM
ZA201404689B (en) Umbilical splint and method of use
HUE037040T2 (hu) Rezveratrol és karboximetil-glükán asszociátuma
EP2852413A4 (en) XENOANTIGEN WITH VACCINES AGAINST CANCER AND MANUFACTURING PROCESS THEREFOR
EP2906576A4 (en) GLYCOSPHINGOLIPIDES AND METHOD OF USE THEREOF